United Therapeutics Corp (UTHR) Reports Q4 EPS of $0.79, Reaffirms FY12, FY13 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $598.72 +0.87%
EPS Growth %: -13.3%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: -13.3%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q4 EPS of $0.79, $0.08 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $195.2 million versus the consensus estimate of $204.81 million.
United Therapeutics Corp reaffirmed FY2012 guidance.
For earnings history and earnings-related data on United Therapeutics Corp (UTHR) click here.
United Therapeutics Corp reaffirmed FY2012 guidance.
For earnings history and earnings-related data on United Therapeutics Corp (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- New Break Resources plans $550,000 flow-through share offering
- Goldman Sachs Revises China Jewelry Stocks Amid Gold Price Retreat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
